Endogenous Regeneration in Parkinson's Disease: Do We Need Orthotopic Dopaminergic Neurogenesis?

被引：24
|
作者：
Hermann, Andreas [1 ,2 ]
Storch, Alexander [1 ,2 ]
机构：
[1] Tech Univ Dresden, Dept Neurol, D-01307 Dresden, Germany
[2] Tech Univ Dresden, Ctr Regenerat Therapies Dresden, D-01307 Dresden, Germany
来源：
STEM CELLS | 2008年 / 26卷 / 11期
关键词：
Endogenous neural stem cells; Neural differentiation; Parkinson's disease; Stem/progenitor cell;
D O I：
10.1634/stemcells.2008-0567
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
引用
收藏
页码：2749 / 2752
页数：4
相关论文
共 50 条
  • [1] Do we need to redefine the advanced stage in Parkinson's disease?
    Sesar, Angel
    Fernandez-Pajarin, Gustavo
    Ares, Begona
    Castro, Alfonso
    REVISTA MEXICANA DE NEUROCIENCIA, 2021, 22 (04): : 152 - 158
  • [2] Biosensors for Parkinson's Disease: Where Are We Now, and Where Do We Need to Go?
    Maddocks, Grace M.
    Eisenstein, M.
    Soh, H. Tom
    ACS SENSORS, 2024, 9 (09): : 4307 - 4327
  • [3] Do We Need to Rethink the Epidemiology and Healthcare Utilization of Parkinson's Disease in Germany?
    Heinzel, Sebastian
    Berg, Daniela
    Binder, Sebastian
    Ebersbach, Georg
    Hickstein, Lennart
    Herbst, Heinz
    Lorrain, Michael
    Wellach, Ingmar
    Maetzler, Walter
    Petersen, Gudula
    Schmedt, Niklas
    Volkmann, Jens
    Woitalla, Dirk
    Amelung, Volker
    FRONTIERS IN NEUROLOGY, 2018, 9
  • [4] Parkinson's Disease and COVID-19: Do We Need to Be More Patient?
    Gonzalez-Latapi, Paulina
    Fearon, Conor
    Fasano, Alfonso
    Lang, Anthony E.
    MOVEMENT DISORDERS, 2021, 36 (02) : 277 - 277
  • [5] Neuropsychiatric Disorders in Parkinson's Disease: What Do We Know About the Role of Dopaminergic and Non-dopaminergic Systems?
    Dujardin, Kathy
    Sgambato, Veronique
    FRONTIERS IN NEUROSCIENCE, 2020, 14
  • [6] Neurorestoration in Parkinson's disease by cell replacement and endogenous regeneration
    Hermann, A
    Gerlach, M
    Schwarz, J
    Storch, A
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2004, 4 (02) : 131 - 143
  • [7] Reply to: "Parkinson's Disease and COVID-19: Do We Need to Be More Patient?"
    Outeiro, Tiago F.
    Krisko, Anita
    MOVEMENT DISORDERS, 2021, 36 (02) : 278 - 279
  • [8] Recovery of Impaired Endogenous Pain Modulation by Dopaminergic Medication in Parkinson's Disease
    Florin, Esther
    Koschmieder, Kim C.
    Schnitzler, Alfons
    Becker, Susanne
    MOVEMENT DISORDERS, 2020, 35 (12) : 2338 - 2343
  • [9] Tricyclic antidepressants delay the need for dopaminergic therapy in early Parkinson's disease
    Paumier, Katrina L.
    Siderowf, Andrew D.
    Auinger, Peggy
    Oakes, David
    Madhavan, Lalitha
    Espay, Alberto J.
    Revilla, Fredy J.
    Collier, Timothy J.
    MOVEMENT DISORDERS, 2012, 27 (07) : 880 - 887
  • [10] Adult neurogenesis in Parkinson's disease
    Marxreiter, Franz
    Regensburger, Martin
    Winkler, Jurgen
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2013, 70 (03) : 459 - 473
12345